1fl1: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
[[Image:1fl1.jpg|left|200px]]
[[Image:1fl1.jpg|left|200px]]


{{Structure
<!--
|PDB= 1fl1 |SIZE=350|CAPTION= <scene name='initialview01'>1fl1</scene>, resolution 2.20&Aring;
The line below this paragraph, containing "STRUCTURE_1fl1", creates the "Structure Box" on the page.
|SITE=
You may change the PDB parameter (which sets the PDB file loaded into the applet)
|LIGAND= <scene name='pdbligand=K:POTASSIUM+ION'>K</scene>
or the SCENE parameter (which sets the initial scene displayed when the page is loaded),
|ACTIVITY=
or leave the SCENE parameter empty for the default display.
|GENE=
-->
|DOMAIN=
{{STRUCTURE_1fl1|  PDB=1fl1 |  SCENE= }}  
|RELATEDENTRY=[[1at3|1AT3]], [[1vzv|1VZV]], [[1cmv|1CMV]], [[1wpo|1WPO]], [[1lay|1LAY]]
|RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1fl1 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1fl1 OCA], [http://www.ebi.ac.uk/pdbsum/1fl1 PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=1fl1 RCSB]</span>
}}


'''KSHV PROTEASE'''
'''KSHV PROTEASE'''
Line 29: Line 26:
[[Category: Reiling, K K.]]
[[Category: Reiling, K K.]]
[[Category: Stroud, R M.]]
[[Category: Stroud, R M.]]
[[Category: antiviral drug design]]
[[Category: Antiviral drug design]]
[[Category: assemblin]]
[[Category: Assemblin]]
[[Category: capsid maturation]]
[[Category: Capsid maturation]]
[[Category: endopeptidase]]
[[Category: Endopeptidase]]
[[Category: serine protease]]
[[Category: Serine protease]]
 
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May  2 16:27:10 2008''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Mar 30 20:25:00 2008''

Revision as of 16:27, 2 May 2008

File:1fl1.jpg

Template:STRUCTURE 1fl1

KSHV PROTEASE


OverviewOverview

The structure of Kaposi's sarcoma-associated herpesvirus protease (KSHV Pr), at 2.2 A resolution, reveals the active-site geometry and defines multiple possible target sites for drug design against a human cancer-producing virus. The catalytic triad of KSHV Pr, (Ser114, His46, and His157) and transition-state stabilization site are arranged as in other structurally characterized herpesviral proteases. The distal histidine-histidine hydrogen bond is solvent accessible, unlike the situation in other classes of serine proteases. As in all herpesviral proteases, the enzyme is active only as a weakly associated dimer (K(d) approximately 2 microM), and inactive as a monomer. Therefore, both the active site and dimer interface are potential targets for antiviral drug design. The dimer interface in KSHV Pr is compared with the interface of other herpesviral proteases. Two conserved arginines (Arg209), one from each monomer, are buried within the same region of the dimer interface. We propose that this conserved arginine may provide a destabilizing element contributing to the tuned micromolar dissociation of herpesviral protease dimers.

About this StructureAbout this Structure

1FL1 is a Single protein structure of sequence from Human herpesvirus 8. Full crystallographic information is available from OCA.

ReferenceReference

Functional consequences of the Kaposi's sarcoma-associated herpesvirus protease structure: regulation of activity and dimerization by conserved structural elements., Reiling KK, Pray TR, Craik CS, Stroud RM, Biochemistry. 2000 Oct 24;39(42):12796-803. PMID:11041844 Page seeded by OCA on Fri May 2 16:27:10 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA